Integrated BioPharma, Inc. INBP
Set alert
0.17 USD 0.00 0.00%
At close · Oct 30
0.165 Day range 0.165
0.15 52-week range 0.38
- YTD
- -52.78%
- 1 year
- -43.33%
- Open
- 0.165
- Prev close
- 0.17
- Mkt cap
- 5.28M
- Vol
- 16.49K
- Avg vol
- 8.76K
- EPS
- -0.09
- P/E
- 0.00
More statistics
- Low
- 0.165
- High
- 0.165
Financials — quick view
INBP Revenue — quarterly 12.91M
INBP Net income — quarterly -59.00K
INBP EPS — quarterly 0.00
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 13, 2024 | Sep 1, 2024 | 0.00 | 0.01 | — | — |
| Sep 20, 2024 | Jun 1, 2024 | 0.00 | 0.01 | — | — |
| May 10, 2024 | Mar 1, 2024 | 0.00 | 0.01 | — | — |
| Feb 12, 2024 | Dec 1, 2023 | 0.00 | -0.01 | — | — |
| Nov 9, 2023 | Sep 1, 2023 | 0.00 | 0.00 | — | — |
| Sep 15, 2023 | Jun 1, 2023 | 0.00 | 0.00 | — | — |
News
- Integrated BioPharma Reports Results for its Quarter and Fiscal Year Ended June 30, 2026
- Integrated BioPharma Reports Results for its Quarter Ended March 31, 2026
- Integrated BioPharma Reports Results for Its Quarter Ended December 31, 2025
- Rentschler Biopharma and Coriolis Pharma announce strategic collaboration for integrated biopharma solutions
- Integrated BioPharma Reports Results for Its Quarter Ended September 30, 2025
- Integrated BioPharma Reports Results for its Quarter and Fiscal Year Ended June 30, 2025
- Integrated BioPharma Reports Results for its Quarter Ended March 31, 2025
- Integrated BioPharma Reports Results for its Quarter Ended December 31, 2024
- Integrated BioPharma Reports Results for its Quarter Ended September 30, 2024
- Integrated BioPharma Reports Results for Its Quarter and Fiscal Year Ended June 30, 2024
Your note
Sign in to keep a note on INBP — it syncs with the Stock Master app.